We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OBSV market cap is 8.14M. The company's latest EPS is USD -0.3737 and P/E is -0.27.
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 19.64M |
Operating Income | -77.15M | -107.1M | -79.7M | -54.51M | -15.68M |
Net Income | -76.72M | -108.79M | -82.97M | -58.38M | -29.88M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 167.44M | 103.94M | 65.45M | 88.99M | 16.54M |
Total Liabilities | 20.52M | 54.99M | 57.09M | 56.65M | 8.06M |
Total Equity | 146.92M | 48.96M | 8.35M | 32.34M | 8.48M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | |||||
Investing | |||||
Financing |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -63.94M | -90.61M | -70.77M | -70.3M | -23.15M |
Investing | -271k | -5.05M | -5k | 22.19M | 3k |
Financing | 91.65M | 26.63M | 32.25M | 71.1M | -16.81M |
Market Cap | 8.14M |
Price to Earnings Ratio | -0.27 |
Price to Sales Ratio | 0.41 |
Price to Cash Ratio | 0.95 |
Price to Book Ratio | 0.94 |
Dividend Yield | - |
Shares Outstanding | 79.96M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (4.06%) |
Company Name | ObsEva SA |
Address |
chemin des aulx, 12 geneva 1228 |
Website | https://www.obseva.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions